• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RETRACTABLE TECHNOLOGIES, INC. VANISHPOINT INSULIN SYRINGE U-100

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RETRACTABLE TECHNOLOGIES, INC. VANISHPOINT INSULIN SYRINGE U-100 Back to Search Results
Model Number U-100
Device Problem Device Inoperable (1663)
Patient Problem No Information (3190)
Event Date 05/07/2016
Event Type  Injury  
Event Description
Insulin syringe retractable point did not function.The syringe we use had malfunctioned several times for me (this is at least the third time) since we have started using them.Vanishpoint insulin syringe nafdac #03-0623, ref (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VANISHPOINT INSULIN SYRINGE U-100
Type of Device
VANISHPOINT INSULIN SYRINGE
Manufacturer (Section D)
RETRACTABLE TECHNOLOGIES, INC.
little elm TX 75068
MDR Report Key5646264
MDR Text Key44985031
Report NumberMW5062186
Device Sequence Number1
Product Code MEG
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 05/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberU-100
Device Catalogue Number15221
Device Lot Number15221
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-